(2Z,3E)-3-((2-(1-Methylpiperidin-2-yl)ethoxy)imino)-5'-nitro-[2,3'-biindolinylidene]-2'-one

ID: ALA5175623

PubChem CID: 168276939

Max Phase: Preclinical

Molecular Formula: C24H25N5O4

Molecular Weight: 447.50

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CN1CCCCC1CCO/N=C1C(=C2/C(=O)Nc3ccc([N+](=O)[O-])cc32)/Nc2ccccc2/1

Standard InChI:  InChI=1S/C24H25N5O4/c1-28-12-5-4-6-15(28)11-13-33-27-22-17-7-2-3-8-19(17)25-23(22)21-18-14-16(29(31)32)9-10-20(18)26-24(21)30/h2-3,7-10,14-15,25H,4-6,11-13H2,1H3,(H,26,30)/b23-21-,27-22+

Standard InChI Key:  FXBIAOYDLBLCFX-WKVCDGSWSA-N

Molfile:  

 
     RDKit          2D

 33 37  0  0  0  0  0  0  0  0999 V2000
   -1.9525   -1.3868    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6671   -1.7991    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6671   -2.6276    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9507   -3.0357    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2406   -2.6239    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4577   -2.8698    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0342   -2.2022    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8594   -2.2022    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4146   -2.8066    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2010   -3.6037    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.1744   -2.4745    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.0935   -1.6730    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6671   -1.0515    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4122   -0.2494    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5944   -0.0667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0230   -0.6858    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2721   -1.4876    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4364   -1.5486    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2406   -1.7987    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2229   -0.7514    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8063   -0.1678    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5928    0.6290    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1762    1.2125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9627    2.0096    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5462    2.5931    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3326    3.3901    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5356    3.6037    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0478    3.0202    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1656    2.2231    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.4178    1.6396    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3809    0.7302    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.9643    1.3137    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.5838    0.9438    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  8  7  2  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
 12 11  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 17 16  1  0
 17 12  2  0
 17  8  1  0
 18  7  1  0
 19 18  1  0
 19  1  1  0
  5 19  2  0
 18 20  2  0
 20 21  1  0
 22 21  1  0
 22 23  1  0
 23 24  1  0
 25 24  1  0
 26 25  1  0
 27 26  1  0
 28 27  1  0
 29 28  1  0
 24 29  1  0
 29 30  1  0
 15 31  1  0
 31 32  1  0
 31 33  2  0
  5  6  1  0
  6  7  1  0
M  CHG  2  31   1  32  -1
M  END

Alternative Forms

  1. Parent:

    ALA5175623

    ---

Associated Targets(Human)

ASF1A Tchem Histone chaperone ASF1A (46 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TLK2 Tchem Serine/threonine-protein kinase tousled-like 2 (710 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-231 (73002 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 447.50Molecular Weight (Monoisotopic): 447.1907AlogP: 3.98#Rotatable Bonds: 5
Polar Surface Area: 109.10Molecular Species: BASEHBA: 7HBD: 2
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 10.26CX Basic pKa: 9.50CX LogP: 2.74CX LogD: 0.91
Aromatic Rings: 2Heavy Atoms: 33QED Weighted: 0.31Np Likeness Score: -0.45

References

1. Lee SB, Chang TY, Lee NZ, Yu ZY, Liu CY, Lee HY..  (2022)  Design, synthesis and biological evaluation of bisindole derivatives as anticancer agents against Tousled-like kinases.,  227  [PMID:34662748] [10.1016/j.ejmech.2021.113904]
2. Miknis, Greg F; Stevens, Sarah J; Smith, Luke E; Ostrov, David A and Churchill, Mair E A.  2015-02-15  Development of novel Asf1-H3/H4 inhibitors.  [PMID:25582598]

Source